Biotech

All Articles

Relay dislikes SHP2 inhibitor after Genentech leaves behind

.Three weeks after Roche's Genentech unit ignored an SHP2 inhibitor pact, Relay Rehab has actually c...

Stoke's Dravet syndrome med discharged of partial clinical hold

.Stoke Therapeutics' Dravet disorder drug has been actually freed from a partial grip, removing the ...

Fierce Biotech's Gabrielle Masson shows Tough 15 at NYSE

.Brutal Biotech Affiliate Editor Gabrielle Masson offered the 2024 class of Ferocious 15 champions o...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its own once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) ...

Daiichi pays Merck $170M to develop lung cancer cells T-cell engager contract

.Merck &amp Co. has actually rapidly recovered a few of the costs of its Harpoon Rehabs buyout, draw...

BioMarin stops preclinical gene therapy for heart condition

.After BioMarin carried out a springtime well-maintained of its own pipe in April, the provider has ...

Eisai vegetations molecular glue SEED with $1.5 B biobucks deal

.Huge Pharmas stay stuck to the concept of molecular glue degraders. The current firm to observe an ...

Life scientific research credit rating agency reveals with $600M

.A new global life science credit rating organization, called Symbiotic Financing, has actually rais...

BMS channels TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more large bet from the Caforio time, terminating a deal...

Nuvation halts BET inhibitor after looking at stage 1 data

.After taking a look at stage 1 information, Nuvation Bio has chosen to halt focus on its own single...